(PharmaNewsWire.Com, November 15, 2017 ) North America Antivenom Market is expected to reach USD 542.4 million by 2021 from USD 427.6 million in 2016, growing at a CAGR of 4.87% during the forecast period 2016-2021. Antivenom is described as the biological product that detoxifies poisoning of venomous bites. Anti-venom Market is prepared from the milking venom of animals such as snakes, spiders, scorpions, and other venomous animals. Venomous bites result in certain clinical conditions such as secretion of excessive saliva, muscle weakness, breathing problems, and other difficulties that may lead to death also. It is estimated that, approximately 3000- 8000 people are recorded with snake bites annually in North America. To overcome poisonous effects after venomous bites manufacturers developed number of Antivenom products including vaccines and hyperimmune sera.
Establishment new snake poison control centres, increasing antivenom products approval, growing research to support the development of effective antivenom products, rising number of clinical trial centres to conduct antivenom products study, increasing fear among people about snake bites, and presence of well-established medical care are driving the growth of North America Antivenom Market. However, stringent regulatory pathways and cost pertaining to manufacturing of antivenom products are expected to restrain the growth of North America Antivenom Market. North America Antivenom market is broadly categorized into type and animal. On the basis of type, North America Antivenom market is segmented into Vaccines and Hyperimmune Sera (Homologous & Heterologous). Based on animal the market is segmented into Snakes, Scorpions, Spiders, and Others. On the basis of geography, the North America Antivenom market is segmented into United States and Canada.
Key market players in the Antivenom market include Instituto Bioclon, S.A. de C.V. (Mexico), Pfizer AG (Switzerland), CSL Limited (Australia), F. Hoffmann-La Roche Ltd. (Switzerland), Merck & Co., Inc. (U.S.), Rare Disease Therapeutics, Inc. (U.S.), Vins Bioproducts Limited (India), BTG Plc (U.K.), Incepta Vaccine Ltd. (Bangladesh), and Bharat Serum and Vaccines Limited (BSV) (India).
Market Segmentation
1) Type Introduction Vaccines Hyperimmune Sera Homologous Heterologous Growth Analysis, By type Attractiveness Analysis, By Type Market Share Analysis, By Type
2) Animal Introduction Snakes Scorpions Spiders Others Y-o-Y Growth Analysis, By Animal Market Attractiveness Analysis, By Animal Market Share Analysis, By Animal
Scope of the Report Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped Segment-level analysis in terms of Type, and Animal along with market size forecasts and estimations to detect key areas of industry growth in detail Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of the effect of exogenous and endogenous factors that affect the North America market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
